Case reports indicate that MPPGL associated with pathogenic SDHB variants might respond to temozolomide,74 although the responses might be independent of the tumor genotype.75 Altogether, the addition of olaparib to temozolomide might lead to disease stabilization and prevent the emergence of tumor resistance. This evidence concerns the gene SDHB and neoplasm.